In this model, Klk8 may facilitate the attenuation of tumor-suppressive signaling within the cancer cells9 or diminish the bioavailability of Activin-A for another specific cell type that facilitates their killing (Fig. 6G). This evidence concerns the gene KLK8 and neoplasm.